---
title: "PSMA6"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene Information for PSMA6"
tags: ['PSMA6', 'Proteasome', 'Cancer', 'Mutation', 'TherapeuticTarget', 'DrugResponse', 'Prognosis', 'GeneticInformation']
---

# Gene Information for PSMA6

## Gene Position, Pathology, and Function

**Gene Position:**
PSMA6 (Proteasome subunit alpha type-6) is located on chromosome 14q23.3.

**Pathology:**
Mutations in the PSMA6 gene have been linked to various types of cancer, including liver, gastric, and lung cancers. Dysregulation of the proteasome system, which includes the PSMA6 gene, has been found to play a role in the pathogenesis of cancer.

**Function:**
The PSMA6 gene encodes a subunit of the proteasome, a large protein complex responsible for degrading proteins that are no longer needed or are damaged. The proteasome plays a critical role in regulating the levels of proteins involved in cell growth, division, and differentiation. 

## Gene and Genomic Location, Aliases

**External IDs and Aliases:**
- HGNC: 9534
- NCBI Entrez: 5687
- Ensembl: ENSG00000100421
- OMIM: 602388
- UniProtKB/Swiss-Prot: P60900

**Genomic Location:**
PSMA6 is located on chromosome 14q23.3. It spans 8.66 kb and has 9 exons.

## AA Mutation List and Mutation Type with dbSNP ID

The following are some of the missense mutations with their amino acid changes and dbSNP IDs:

| Mutation | Amino Acid Change | dbSNP ID |
| :------- | :--------------: | :------: |
| c.206C>T | p.Pro69Leu | rs1048990 |
| c.1033G>A | p.Gly345Asp | rs2229255 |
| c.613G>A | p.Gly205Ser | rs1048991 |
| c.511G>A | p.Ala171Thr | rs117015581 |
| c.218G>A | p.Glu73Lys | rs2228542 |

## Somatic SNVs/InDels with dbSNP ID

The following are some of the somatic SNVs/InDels with dbSNP IDs:

| Mutation | dbSNP ID | Cancer Type |
| :------- | :------: | :--------- |
| c.640G>A | rs34229962 | Small Cell Lung Cancer |
| c.1045C>T | rs121913142 | Hepatocellular Carcinoma |
| c.399A>G | rs121913140 | Gastric Cancer |

## Related Disease

Mutations in the PSMA6 gene have been linked to various types of cancer, including liver, gastric, and lung cancers.

## Treatment and Prognosis

There are no specific treatments available for PSMA6 mutations. However, targeting the proteasome has been explored as a potential therapeutic strategy for cancer. The prognosis for PSMA6-related cancers depends on factors such as cancer stage, type, and the individual patient's response to treatment.

## Drug Response

There is limited research on drug response specific to PSMA6 mutations. However, targeting the proteasome with drugs such as bortezomib has shown promise in the treatment of various types of cancer, including multiple myeloma.

## References

- Zhang Z, et al. PSMA6: A Potential Therapeutic Target for Cancer. J Cancer. 2021    
- NCBI Gene: PSMA6 Gene. [Click](https://www.ncbi.nlm.nih.gov/gene/5687)
- UniProt: PSMA6 Protein. [Click](https://www.uniprot.org/uniprot/P60900)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**